Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Eichenauer, Dennis A;Aleman, Berthe M P;André, Marc;Federico, Massimo;ESMO Guidelines Committee;et.al.
(2018) Annals of Oncology — Vol. 29, n° Suppl 4, p. iv19-iv29 (2018)

Files

EichenauerDAAnnOncol2018.pdf
  • Open Access
  • Adobe PDF
  • 468.12 KB
Download

Details

Authors
  • Eichenauer, Dennis A
    Author
  • Aleman, Berthe M P
    Author
  • André, MarcUCLouvain
    Author
  • Federico, Massimo
    Author
  • ESMO Guidelines Committee
    Collaborator
Show more
Abstract
(en) The crude incidence of Hodgkin lymphoma (HL) in the European Union is 2.3, the mortality 0.4 cases/100 000/year. Young adults aged 20–40 years are most often affected. Slightly more men than women are diagnosed with HL. Histologically, classical HL (cHL) accounting for 95% of all HL cases is distinguished from nodular lymphocyte-predominant HL (NLPHL) representing 5% of all HL cases. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Eichenauer, D. A., Aleman, B. M. P., André, M., Federico, M., Hutchings, M., Illidge, T., Engert, A., & Ladetto, M. (2018). Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 29(Suppl 4), iv19-iv29. https://doi.org/10.1093/annonc/mdy080 (Original work published 2018)